Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2001 Jul;85(1):F18–F22. doi: 10.1136/fn.85.1.F18

Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature

J Hartmann, A Hussein, E Trowitzsch, J Becker, K Hennecke
PMCID: PMC1721267  PMID: 11420316

Abstract

BACKGROUND—Thrombosis is a relatively rare event in children. However, many conditions in the neonatal period result in an increased risk of thrombus formation. The major risk factor is the indwelling intravascular catheter. Numerous small studies have reported experience of thrombolytic treatment for neonatal thrombotic disease with a wide range of different thrombolytic agents in various forms of administration, dosage, and duration, but no conclusions on the most effective treatment for neonates has been reached.
OBJECTIVE—To assess the efficacy and safety of thrombolytic treatment of neonatal catheter related thrombus (CRT) formation with recombinant tissue plasminogen activator (rt-PA).
METHOD—Over a six year period, 14 neonates with CRT were treated with the same rt-PA protocol (an initial bolus of 0.7 mg/kg over 30-60 minutes followed by infusion of 0.2 mg/kg/h).
RESULTS—Complete clot dissolution was documented in 11 patients, and partial clot lysis in two patients, leading to a patency rate of 94%. In two cases, local bleeding occurred, resulting in treatment failure in one case. Finally, antithrombin III substitution was required in one case. No other complications such as severe bleeding were recognised.
CONCLUSION—With the use of close clinical and haematological monitoring on a neonatal intensive care unit combined with serial two dimensional colour echocardiography, the present rt-PA protocol was shown to be a safe and effective method of clot dissolution in neonates.



Full Text

The Full Text of this article is available as a PDF (155.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahluwalia J. S., Kelsall A. W., Diederich S., Rennie J. M. Successful treatment of aortic thrombosis after umbilical catheterization with tissue plasminogen activator. Acta Paediatr. 1994 Nov;83(11):1215–1217. doi: 10.1111/j.1651-2227.1994.tb18286.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson B. J., Keeley S. R., Johnson N. D. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator. Anaesth Intensive Care. 1991 Feb;19(1):22–27. doi: 10.1177/0310057X9101900104. [DOI] [PubMed] [Google Scholar]
  3. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995 Jul;74(1):415–425. [PubMed] [Google Scholar]
  4. Andrew M., Michelson A. D., Bovill E., Leaker M., Massicotte M. P. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr. 1998 Apr;132(4):575–588. doi: 10.1016/s0022-3476(98)70343-9. [DOI] [PubMed] [Google Scholar]
  5. Aspesberro F., Beghetti M., Oberhänsli I., Ozsahin H., Humbert J., Rimensberger P. C. Local low-dose urokinase treatment of acquired intracardiac thrombi in preterm infants. Eur J Pediatr. 1999 Sep;158(9):698–701. doi: 10.1007/s004310051182. [DOI] [PubMed] [Google Scholar]
  6. Atkinson J. B., Bagnall H. A., Gomperts E. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters. JPEN J Parenter Enteral Nutr. 1990 May-Jun;14(3):310–311. doi: 10.1177/0148607190014003310. [DOI] [PubMed] [Google Scholar]
  7. Berman W., Jr, Fripp R. R., Yabek S. M., Wernly J., Corlew S. Great vein and right atrial thrombosis in critically ill infants and children with central venous lines. Chest. 1991 Apr;99(4):963–967. doi: 10.1378/chest.99.4.963. [DOI] [PubMed] [Google Scholar]
  8. Cinà C. S., Goh R. H., Chan J., Kenny B., Evans G., Rawlinson J., Gill G. Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator. Ann Vasc Surg. 1999 Nov;13(6):571–575. doi: 10.1007/s100169900300. [DOI] [PubMed] [Google Scholar]
  9. Colnaghi C., Cazzuffi M. A., Introvini P., Fornerone R., Sabatini I., Borin F., Magni L. A. Urochinasi nel prematuro: utilizzo in un caso di trombosi atrial destra secondaria a cateterizzazione della vena ombelicale. Pediatr Med Chir. 1995 May-Jun;17(3):275–277. [PubMed] [Google Scholar]
  10. Coon W. W., Willis P. W., 3rd, Keller J. B. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973 Oct;48(4):839–846. doi: 10.1161/01.cir.48.4.839. [DOI] [PubMed] [Google Scholar]
  11. David M., Manco-Johnson M., Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995 Aug;74(2):791–792. [PubMed] [Google Scholar]
  12. Deeg K. H., Wölfel D., Rupprecht T. Diagnosis of neonatal aortic thrombosis by colour coded Doppler sonography. Pediatr Radiol. 1992;22(1):62–63. doi: 10.1007/BF02011611. [DOI] [PubMed] [Google Scholar]
  13. Dillon P. W., Fox P. S., Berg C. J., Cardella J. F., Krummel T. M. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg. 1993 Oct;28(10):1264–1269. doi: 10.1016/s0022-3468(05)80310-0. [DOI] [PubMed] [Google Scholar]
  14. Doyle E., Britto J., Freeman J., Munro F., Morton N. S. Thrombolysis with low dose tissue plasminogen activator. Arch Dis Child. 1992 Dec;67(12):1483–1484. doi: 10.1136/adc.67.12.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Farnoux C., Camard O., Pinquier D., Hurtaud-Roux M. F., Sebag G., Schlegel N., Beaufils F. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998 Jul;133(1):137–140. doi: 10.1016/s0022-3476(98)70193-3. [DOI] [PubMed] [Google Scholar]
  16. Giacoia G. P. High-dose urokinase therapy in newborn infants with major vessel thrombosis. Clin Pediatr (Phila) 1993 Apr;32(4):231–237. doi: 10.1177/000992289303200409. [DOI] [PubMed] [Google Scholar]
  17. Haire W. D., Atkinson J. B., Stephens L. C., Kotulak G. D. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost. 1994 Oct;72(4):543–547. [PubMed] [Google Scholar]
  18. Holden R. W. Plasminogen activators: pharmacology and therapy. Radiology. 1990 Mar;174(3 Pt 2):993–1001. doi: 10.1148/radiology.174.3.174-3-993. [DOI] [PubMed] [Google Scholar]
  19. Häusler M., Duque D., Merz U., Mertens R., Mühler E., Hörnchen H. The clinical outcome after inferior vena cava thrombosis in early infancy. Eur J Pediatr. 1999 May;158(5):416–420. doi: 10.1007/s004310051105. [DOI] [PubMed] [Google Scholar]
  20. Kennedy L. A., Drummond W. H., Knight M. E., Millsaps M. M., Williams J. L. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr. 1990 May;116(5):798–801. doi: 10.1016/s0022-3476(05)82675-7. [DOI] [PubMed] [Google Scholar]
  21. Kothari S. S., Varma S., Wasir H. S. Thrombolytic therapy in infants and children. Am Heart J. 1994 Mar;127(3):651–657. doi: 10.1016/0002-8703(94)90676-9. [DOI] [PubMed] [Google Scholar]
  22. Leaker M., Massicotte M. P., Brooker L. A., Andrew M. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost. 1996 Aug;76(2):132–134. [PubMed] [Google Scholar]
  23. Levy M., Benson L. N., Burrows P. E., Bentur Y., Strong D. K., Smith J., Johnson D., Jacobson S., Koren G. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr. 1991 Mar;118(3):467–472. doi: 10.1016/s0022-3476(05)82170-5. [DOI] [PubMed] [Google Scholar]
  24. Manco-Johnson M. J. Diagnosis and management of thromboses in the perinatal period. Semin Perinatol. 1990 Oct;14(5):393–402. [PubMed] [Google Scholar]
  25. Manco-Johnson M. J. Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Thromb Haemost. 1997 Jul;78(1):710–714. [PubMed] [Google Scholar]
  26. Marder V. J., Sherry S. Thrombolytic therapy: current status (1). N Engl J Med. 1988 Jun 9;318(23):1512–1520. doi: 10.1056/NEJM198806093182306. [DOI] [PubMed] [Google Scholar]
  27. Mehta S., Connors A. F., Jr, Danish E. H., Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: a prospective study. J Pediatr Surg. 1992 Jan;27(1):18–22. doi: 10.1016/0022-3468(92)90095-o. [DOI] [PubMed] [Google Scholar]
  28. Michelson A. D., Bovill E., Andrew M. Antithrombotic therapy in children. Chest. 1995 Oct;108(4 Suppl):506S–522S. doi: 10.1378/chest.108.4_supplement.506s. [DOI] [PubMed] [Google Scholar]
  29. Naylor C. D., Armstrong P. W. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy. CMAJ. 1989 Jun 1;140(11):1289–1299. [PMC free article] [PubMed] [Google Scholar]
  30. Nowak-Göttl U., Auberger K., Halimeh S., Junker R., Klinge J., Kreuz W. D., Ries M., Schlegel N. Thrombolysis in newborns and infants. Thromb Haemost. 1999 Sep;82 (Suppl 1):112–116. [PubMed] [Google Scholar]
  31. Nowak-Göttl U., Kreuz W. D., Schwabe D., Linde R., Kornhuber B. Thrombolyse mit rt-PA bei Kindern mit arteriellen und venösen Thrombosen--ein neuer Therapieansatz. Klin Padiatr. 1991 Sep-Oct;203(5):359–362. doi: 10.1055/s-2007-1025453. [DOI] [PubMed] [Google Scholar]
  32. Nowak-Göttl U., Schwabe D., Schneider W., Schlösser R., Kreuz W. Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet. 1992 Oct 31;340(8827):1105–1105. doi: 10.1016/0140-6736(92)93134-9. [DOI] [PubMed] [Google Scholar]
  33. Nowak-Göttl U., von Kries R., Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997 May;76(3):F163–F167. doi: 10.1136/fn.76.3.f163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rehan V. K., Cronin C. M., Bowman J. M. Neonatal portal vein thrombosis successfully treated by regional streptokinase infusion. Eur J Pediatr. 1994 Jun;153(6):456–459. doi: 10.1007/BF01983412. [DOI] [PubMed] [Google Scholar]
  35. Schiff D. E., Stonestreet B. S. Central venous catheters in low birth weight infants: incidence of related complications. J Perinatol. 1993 Mar-Apr;13(2):153–158. [PubMed] [Google Scholar]
  36. Schmidt B., Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995 Nov;96(5 Pt 1):939–943. [PubMed] [Google Scholar]
  37. Schmidt B., Andrew M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost. 1992 Mar 2;67(3):381–382. [PubMed] [Google Scholar]
  38. Tanke R. B., van Megen R., Daniëls O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology. 1994 Jun;45(6):477–480. doi: 10.1177/000331979404500610. [DOI] [PubMed] [Google Scholar]
  39. Trusen B., Ries M., Zenker M., Rauh M., Beinder E., Keuper H., Harms D. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA). Semin Thromb Hemost. 1998;24(6):599–604. doi: 10.1055/s-2007-996060. [DOI] [PubMed] [Google Scholar]
  40. Weiner G. M., Castle V. P., DiPietro M. A., Faix R. G. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr. 1998 Jul;133(1):133–136. doi: 10.1016/s0022-3476(98)70192-1. [DOI] [PubMed] [Google Scholar]
  41. Wever M. L., Liem K. D., Geven W. B., Tanke R. B. Urokinase therapy in neonates with catheter related central venous thrombosis. Thromb Haemost. 1995 Feb;73(2):180–185. [PubMed] [Google Scholar]
  42. Zenz W., Arlt F., Sodia S., Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost. 1997;23(3):321–332. doi: 10.1055/s-2007-996104. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES